Lensar (LNSR) EBITDA Margin (2019 - 2026)
Lensar (LNSR) reported EBITDA Margin of 270.54% for Q1 2026, up 46369.0% year-over-year from N/an in Q1 2025, and up 3071.48% on a QoQ basis from 9.1% in Q4 2025.
Lensar (LNSR) has 8 years of EBITDA Margin data on file, last reported at 270.54% in Q1 2026.
- Quarterly EBITDA Margin rose 46369.0% year-over-year to 270.54% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 53.93% (up 16030.0% YoY) and the FY2025 annual result came in at 58.67%, up 965.0% from the prior year.
- EBITDA Margin climbed to 270.54% in Q1 2026 per LNSR's latest filing, from 9.1% in the prior quarter.
- Across five years, EBITDA Margin topped out at 270.54% in Q1 2026 and bottomed at 745.52% in Q1 2024.
- The 5-year median for EBITDA Margin is 29.05% (2025), against an average of 79.16%.
- The widest annual swing landed in 2024, when EBITDA Margin tumbled 69267 bps; it then jumped 55237 bps in 2025.
- Tracing LNSR's EBITDA Margin over 5 years: stood at 25.54% in 2022, then retreated by 10 bps to 28.2% in 2023, then slumped by 348 bps to 126.24% in 2024, then surged by 93 bps to 9.1% in 2025, then jumped by 3071 bps to 270.54% in 2026.
- Per Business Quant, the three latest LNSR EBITDA Margin figures stand at 270.54% (Q1 2026), 9.1% (Q4 2025), and 29.05% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 270.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270.54% |
| Dec 31, 2025 | -9.10% |
| Sep 30, 2025 | -29.05% |
| Jun 30, 2025 | -14.40% |
| Mar 31, 2025 | -193.15% |
| Dec 31, 2024 | -126.24% |
| Sep 30, 2024 | -10.94% |
| Jun 30, 2024 | -84.69% |
| Mar 31, 2024 | -745.52% |
| Dec 31, 2023 | -28.20% |
| Sep 30, 2023 | -20.83% |
| Jun 30, 2023 | -23.87% |
| Mar 31, 2023 | -52.85% |
| Dec 31, 2022 | -25.54% |
| Sep 30, 2022 | -65.06% |
| Jun 30, 2022 | -102.64% |
| Mar 31, 2022 | -84.16% |
| Dec 31, 2021 | -26.51% |
| Sep 30, 2021 | -74.53% |
| Jun 30, 2021 | -64.51% |
| Mar 31, 2021 | -87.66% |
| Dec 31, 2020 | -63.39% |
| Sep 30, 2020 | -65.95% |
| Jun 30, 2020 | -76.14% |
| Mar 31, 2020 | -52.47% |
| Dec 31, 2019 | -16.60% |
| Sep 30, 2019 | -66.15% |